Memphis, TN / New Orleans, LA, August 13, 2004--Procter and Gamble (P&G) has awarded GeneScan USA with the prestigious Pinnacle Award for Excellence in Good Laboratory Practices and Quality Systems. As part of its quality assurance program, P&G conducts vendor audits to provide independent assessments of the current conditions in facilities that manufacture, handle, or store its products. To obtain a satisfactory assessment, a laboratory must demonstrate its commitment to achieving high technical standards, maintaining operational efficiency, and improving its processes to ensure customer satisfaction. This year marks the fourth consecutive year that GeneScan has achieved this distinction after scoring a 100% QA rating during this year’s audit, which comes a month after the bioanalytical company successfully renewed its ISO / IEC - 17025 accreditation by the American Association of Laboratory Accreditation (A2LA) for the detection and quantification of genetically modified food and agricultural products.
One of the goals of GeneScan is to provide its clients with scientific expertise and unparalleled customer service. In accordance with this goal, the GMO testing leader’s commitment to quality is further demonstrated through its successful completion of proficiency testing with the USDA Grain Inspection, Packers and Stockyards Administration (GIPSA), which includes a history of ten consecutive 100% ratings since 2002. In addition, GeneScan became the only US laboratory accredited for GMO testing by New Zealand’s Ministry of Agriculture and Forestry in April 2004 and also received the 2004 Lantern Award for Biotechnology from the State of Louisiana. These achievements are further evidence of GeneScan’s overall excellence and recognized level of quality and performance.
Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of bioanalytical support services utilizing the latest developments in biotechnology. The Group specializes in delivering analytical testing services to clients in a wide range of industries including the pharmaceutical, food, feed, pet food, animal health and dietary supplement sectors. The Eurofins Group aims to be the world market leader in the field of applied life sciences and is pursuing a dynamic expansion strategy to improve both its technology portfolio and its geographic reach. Through R&D, licensing and acquisitions, the Group draws on the latest developments in the field to offer its clients unparalleled analytical solutions.
With over 2,000 staff members in more than 40 laboratories across 12 countries and a portfolio of around 5,000 reliable analytical methods for proving the authenticity, origin, safety, identity, and purity of biological substances, Eurofins Scientific is already a leading global provider of bioanalytical services. The Group is committed to supporting its clients’ objectives of ensuring that their products maintain the best possible quality and safety levels in all markets in which they operate. Eurofins Scientific intends to continue to develop, acquire or license the most comprehensive range of state-of-the-art analytical technologies in order to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.